Related Experiment Videos
A cell biological perspective on Alzheimer's disease
Wim Annaert1, Bart De Strooper
1Neuronal Cell Biology Laboratory, Flanders Interuniversity Institute for Biotechnology (VIB) and Catholic University of Leuven, Center for Human Genetics Herestraat 49, Belgium.
Annual Review of Cell and Developmental Biology
|July 27, 2002
Summary
Alzheimer's disease involves amyloid precursor protein and its cleaving proteases, which generate amyloid peptides. These proteins also play roles in normal cell functions like axonal transport and developmental signaling pathways.
Area of Science:
- Cell Biology
- Developmental Biology
- Neuroscience
Background:
- Alzheimer's disease pathogenesis is linked to amyloid precursor protein (APP) and proteases generating amyloid peptides.
- APP is physiologically involved in axonal vesicular trafficking.
- Proteases cleaving APP are crucial in developmental signaling, particularly regulated intramembrane proteolysis (RIP).
Purpose of the Study:
- To discuss the cell biology underpinning the amyloid and tangle hypotheses of Alzheimer's disease.
- To highlight the connections between Alzheimer's disease pathology and established cell and developmental biology principles.
Main Methods:
- Literature review and synthesis of existing research.
- Discussion of cell biological mechanisms.
- Integration of findings from cell biology and developmental biology.
Main Results:
- The amyloid precursor protein and its processing proteases are central to Alzheimer's disease.
- Physiological roles of APP and proteases in cellular functions are identified.
- Established links between cell biology, developmental biology, and Alzheimer's disease are explored.
Conclusions:
- Understanding the cell biology of APP processing is critical for Alzheimer's disease research.
- The interplay between normal physiological functions and pathological processes in Alzheimer's disease is complex.
- Further research integrating cell and developmental biology perspectives may yield new insights into Alzheimer's disease treatments.